WO2022131613A1 - Cosmetic composition containing mixture of rosmarinic acid and lemon balm leaf extract as active ingredient - Google Patents

Cosmetic composition containing mixture of rosmarinic acid and lemon balm leaf extract as active ingredient Download PDF

Info

Publication number
WO2022131613A1
WO2022131613A1 PCT/KR2021/017657 KR2021017657W WO2022131613A1 WO 2022131613 A1 WO2022131613 A1 WO 2022131613A1 KR 2021017657 W KR2021017657 W KR 2021017657W WO 2022131613 A1 WO2022131613 A1 WO 2022131613A1
Authority
WO
WIPO (PCT)
Prior art keywords
leaf extract
lemon balm
rosmarinic acid
balm leaf
mixture
Prior art date
Application number
PCT/KR2021/017657
Other languages
French (fr)
Korean (ko)
Inventor
박기현
이윤두
지현경
유강민
남성주
이진수
Original Assignee
주식회사 씨엠에스랩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 씨엠에스랩 filed Critical 주식회사 씨엠에스랩
Publication of WO2022131613A1 publication Critical patent/WO2022131613A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Definitions

  • the present invention relates to a cosmetic composition, and more particularly, by containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, maintenance of weakly acidic skin and skin It relates to a cosmetic composition containing, as an active ingredient, a mixture of rosmarinic acid and lemon balm leaf extract, which has a barrier strengthening effect and has various other beneficial effects on the skin.
  • NHE1 Sodium hydrogen exchanger1
  • the most important role of the skin is a function as a defense barrier that protects the body from external damage and invasion of bacteria.
  • the skin is composed of three layers from the outside: the epidermis, the dermis, and the subcutaneous fat. Thus, it functions as the most important barrier to protect the skin from the external environment. Keratinocytes generated in the basal layer of the epidermis reach the stratum corneum and release abundant lipids from the lamellar body. Afterwards, the nucleus is lost and remains as a protein mass, corneocytes. .
  • the stratum corneum is composed of keratinocytes (bricks) and the intercellular lipid membrane (mortar) that fills them, and performs a strong defense function to protect the human body from external physical, chemical, and biological stimuli.
  • the skin surface of a young and healthy person has a slightly acidic pH of about 4.5 to 5.5, and this weakly acidic pH contributes to maintaining the homeostasis of the skin barrier.
  • the skin of the elderly has a slightly higher pH, so it becomes neutral or slightly alkaline.
  • the activity of enzymes involved in the formation of a lipid film is reduced, the corneodesmosome, which tightly binds keratinocytes, is decomposed, and the activity of serine proteases, an enzyme involved in exfoliation of dead skin cells, increases. Barrier dysfunction is caused.
  • NHE-1 sodium-hydrogen exchanger-1
  • Korean Patent No. 10-2014395 discloses a cosmetic composition comprising black cumin extract as an active ingredient, which is a skin pH control factor, sodium/hydrogen ion channel ( By increasing the activity of Na+/H+ Exchanger 1), black cumin (Nigella sativa), which is more essential and continuously maintains the skin pH in a weakly acidic state, improves the skin barrier function, and has an excellent effect on skin flexibility and moisturizing It relates to a cosmetic composition for adjusting skin pH comprising an extract as an active ingredient.
  • the conventional cosmetic composition containing black cumin extract as an active ingredient is difficult to obtain black cumin as a raw material, so there is a need for cosmetics for adjusting skin pH using raw materials that are easy to grow around us.
  • the cosmetic composition comprising the conventional black cumin extract as an active ingredient had a slight pH control effect.
  • NHE1 sodium hydrogen exchanger1
  • Patent Document 0001 Republic of Korea Patent Publication No. 10-2014395 (published on Aug. 26, 2019), "Cosmeceutical composition containing black cumin extract as an active ingredient"
  • the present invention relates to a cosmetic composition, and more particularly, by containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, maintaining weakly acidic skin and It relates to a cosmetic composition containing, as an active ingredient, a mixture of rosmarinic acid and lemon balm leaf extract, which has a skin barrier strengthening effect and has various other beneficial effects on the skin.
  • NHE1 Sodium hydrogen exchanger1
  • the present invention contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient to increase the expression of NHE1 (sodium hydrogen exchanger1), an internal factor that controls skin pH, rosmarinic acid and It provides a cosmetic composition containing a mixture of lemon balm leaf extract as an active ingredient.
  • NHE1 sodium hydrogen exchanger1
  • the mixture of rosmarinic acid and lemon balm leaf extract is dissolved in powdered rosmarinic acid and lemon balm leaf extract in one or more solvents selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol and stirred and mixed.
  • rosmarinic acid and lemon balm leaf extract are mixed in a weight ratio of 0.01 to 10: 0.1 to 90.
  • the lemon balm leaf extract is characterized by hot water extraction with at least one extraction solvent selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol.
  • the cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, and the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that controls skin pH It has the effect of maintaining weakly acidic skin and strengthening the skin barrier by increasing NHE1 (Sodium hydrogen exchanger1), an internal factor that controls skin pH It has the effect of maintaining weakly acidic skin and strengthening the skin barrier by increasing
  • the rosmarinic acid is a kind of polyphenol compound abundantly present in various plants such as rosemary, sesame leaf, and lemon. As a polyphenol component, rosmarinic acid has been studied to have various pharmacological effects such as antioxidant effect.
  • the rosmarinic acid has the form of Formula 1 below.
  • the rosmarinic acid is a caffeic acid ester of dihydroxyphenyl lactic acid [3- (3,4-dihydroxyphenyl) lactic acid].
  • the rosmarinic acid was first extracted and analyzed from rosemary by M. L. Scarpatti and G. Oriente in 1958. It is appropriate to use the rosmarinic acid in powder form, and various products are commercially available for the rosmarinic acid in powder form.
  • the lemon balm leaf extract refers to an extract extracted from the leaves of lemon balm ( Melissa officinalis ).
  • the lemon balm is a cold-resistant perennial plant of the dicotyledonous plant Lamiaceae.
  • the lemon balm is also called melisse citronnelle because it smells like lemon.
  • the alcoholic extract of lemon balm is used as a raw material for l'eau des Carmes, a potion known to strengthen the heart and relieve headaches.
  • the lemon balm can use all of flowers, leaves, and stems, and essential oil is used as an active substance.
  • the mixture of rosmarinic acid and lemon balm leaf extract refers to a mixture of powdered rosmarinic acid and lemon balm leaf extract dissolved in a solvent and stirred.
  • the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient increases the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, has a weakly acidic skin maintenance effect, It has a barrier strengthening effect.
  • NHE1 sodium hydrogen exchanger1
  • the cosmetic composition comprising a mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, thereby providing anti-pollution effect, blackhead removal effect and wrinkle improvement effect It has a variety of beneficial effects on the skin.
  • a mixture of rosmarinic acid and lemon balm leaf extract of Examples 1 to 3 was prepared through the following preparation steps.
  • Example 2 1,3-butylene glycol remaining amount remaining amount Lemon Balm Leaf Extract 50.0 50.0 50.0 Rosmarinic Acid Powder 0.1 1.0 2.0
  • a mixture containing only rosmarinic acid of Comparative Example 1 was prepared through the following preparation steps.
  • a mixture containing only the lemon balm leaf extract of Comparative Example 2 was prepared through the following preparation steps.
  • NHEKs Normal human epidermal keratinocytes
  • KGM Keratinocyte Growth Medium
  • Test samples of Examples 1 to 3 and Comparative Examples 1 and 2 dissolved in KBM by 1000-fold dilution are added to the wells, and after 24 hours of incubation, total RNAs are isolated according to a standard method.
  • NHEKs Normal human epidermal keratinocytes
  • KGM Keratinocyte Growth Medium
  • Examples 1 to 4 and Comparative Examples 1 to 4 dissolved in KBM by 1000-fold dilution were added to the wells, and after 48 hours of incubation, the cells were incubated with 400 ⁇ L of 50 mmol/LTris-HCl buffer (pH7.5, 150 mmol/L NaCl, Dissolve in 1% NonidetP40, 0.5% sodium deoxycholate and protease inhibitor) and centrifuge to remove cell debris.
  • the amount of NHE1 contained in 100 ⁇ L of the protein solution was measured with the NHE1 ELISA Kit (Cloud-Clone Corp.). Simultaneously, the amount of total protein was quantified in 20 ⁇ L of protein solution and the amount of NHE1 per total protein was calculated.
  • the amount of NHE1 per total protein extracted from cells without the addition of Examples 1 to 4 and Comparative Examples 1 to 4 was set to 100, and the NHE1 production promoting effect per total protein extracted from cells of the test sample was evaluated using the following formula.
  • NHE1 protein production promotion rate (%) A / B x 100
  • A Amount of NHE1 per total protein extracted from cells containing the test sample
  • the skin pH is shown in Table 7 below
  • the amount of transdermal water loss is shown in Table 8 below.
  • the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient increases the expression of NHE1 (Sodium hydrogen exchanger1), thereby maintaining a weakly acidic skin effect, preventing transdermal moisture loss, and strengthening the skin barrier effect and the like.
  • NHE1 sodium hydrogen exchanger1
  • the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient additionally has anti-pollution effect, blackhead removal effect and wrinkle improvement effect.
  • rosmarinic acid and lemon balm leaf extract should be mixed in a weight ratio of 0.01: 90 to 0.1: 90 in order to express the above effects at a satisfactory level.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a cosmetic composition which contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, increases the expression of sodium hydrogen exchanger1 (NHE1), which is an internal factor that regulates skin pH, thus having the effect of maintaining weakly acidic skin and strengthening the skin barrier, and has various other beneficial effects on the skin.

Description

로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물Cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient
본 발명은 화장료 조성물에 관한 것으로, 더 자세하게는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여, 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써 약산성 피부 유지 및 피부 장벽 강화 효과를 가지며, 그 외에 피부에 이로운 다양한 효과를 갖도록 한 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition, and more particularly, by containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, maintenance of weakly acidic skin and skin It relates to a cosmetic composition containing, as an active ingredient, a mixture of rosmarinic acid and lemon balm leaf extract, which has a barrier strengthening effect and has various other beneficial effects on the skin.
일반적으로 피부의 가장 중요한 역할은 외부 손상과 세균의 침입 등으로부터 신체를 보호하는 방어 장벽(defense barrier)으로서의 기능이다. 피부는 바깥쪽에서부터 표피(epidermis), 진피(dermis) 및 피하지방층(subcutaneous fat)의 세 층으로 구성되어 있으며, 표피의 최외곽에 위치하는 각질층은 인체 부위에 따라 대략 15층 내지 30층으로 존재하여 외부 환경으로부터 피부를 보호하는 가장 중요한 장벽으로서 기능한다. 표피의 기저층(basal layer)에서 생성된 각질형성세포(keratinocyte)는 각질층에 도달하여 층판소체(lamellar body)로부터 풍부한 지질을 배출하고, 이후 핵이 소실되면서 단백질 덩어리인 각질세포(corneocyte)로 남게 된다. 각질층은 각질세포(벽돌;brick)와 그 사이를 채우고 있는 세포간 지질막(회반죽; mortar)으로 구성되어 외부의 물리적, 화학적, 생물학적 자극으로부터 인체를 보호하는 강력한 방어 기능을 수행한다.In general, the most important role of the skin is a function as a defense barrier that protects the body from external damage and invasion of bacteria. The skin is composed of three layers from the outside: the epidermis, the dermis, and the subcutaneous fat. Thus, it functions as the most important barrier to protect the skin from the external environment. Keratinocytes generated in the basal layer of the epidermis reach the stratum corneum and release abundant lipids from the lamellar body. Afterwards, the nucleus is lost and remains as a protein mass, corneocytes. . The stratum corneum is composed of keratinocytes (bricks) and the intercellular lipid membrane (mortar) that fills them, and performs a strong defense function to protect the human body from external physical, chemical, and biological stimuli.
젊고 건강한 사람의 피부 표면은 pH 4.5 ~ 5.5 정도의 약산성을 띄고 있으며 이러한 약산성의 pH는 피부장벽이 항상성을 유지하는데 기여한다. 하지만, 노인의 피부는 pH가 다소 높아져서 중성 혹은 약알칼리성을 띄게 된다. 이러한 약알칼리성 환경에서는 지질막 형성에 관여하는 효소들의 활성이 감소되고, 각질세포들을 단단히 결합하고 있는 각질교소체(corneodesmosome)가 분해되며, 각질 탈락에 관여하는 효소인 serine protease들의 활성도가 증가하게 되어 피부 장벽기능의 이상이 초래된다. 노화 피부에서는 각질층의 산성 pH를 유지하는데 결정적인 역할을 하는 나트륨-수소이온 교환 펌프(Sodium-hydrogen exchanger-1, NHE-1)의 발현이 감소되어 있는데, 이러한 NHE-1의 감소에 의해 노화 피부가 산성 pH를 유지하지 못하여 그 결과 피부장벽이 손상된 후에 정상으로 회복되는 속도가 크게 저하되는 것으로 생각된다. 따라서, 피부 pH 를 조절할 수 있는 화장료 조성물에 대한 필요성이 커지고 있었다.The skin surface of a young and healthy person has a slightly acidic pH of about 4.5 to 5.5, and this weakly acidic pH contributes to maintaining the homeostasis of the skin barrier. However, the skin of the elderly has a slightly higher pH, so it becomes neutral or slightly alkaline. In such a weakly alkaline environment, the activity of enzymes involved in the formation of a lipid film is reduced, the corneodesmosome, which tightly binds keratinocytes, is decomposed, and the activity of serine proteases, an enzyme involved in exfoliation of dead skin cells, increases. Barrier dysfunction is caused. In aging skin, the expression of sodium-hydrogen exchanger-1 (NHE-1), which plays a decisive role in maintaining the acidic pH of the stratum corneum, is reduced. It is thought that the rate of recovery to normal after the skin barrier is damaged as a result of not maintaining the acidic pH is greatly reduced. Therefore, there has been a growing need for a cosmetic composition capable of adjusting skin pH.
이와 같은 pH 조절과 관련된 종래의 기술로, 대한민국 등록특허공보 제10-2014395호에는 블랙커민 추출물을 유효성분으로 포함하는 화장료 조성물이 개시된 바 있는데, 이는, 피부 pH 조절인자인 나트륨/수소 이온통로(Na+/H+ Exchanger 1)의 활성을 높임으로써, 보다 본질적이고, 지속적으로 피부 pH를 약산성으로 유지시키며, 피부장벽 기능을 개선하고, 피부의 유연성 및 보습에 우수한 효과를 보이는 블랙커민(Nigella sativa)) 추출물을 유효성분으로 포함하는 피부 pH 조절용 화장료 조성물에 관한 것이다.As a prior art related to such pH control, Korean Patent No. 10-2014395 discloses a cosmetic composition comprising black cumin extract as an active ingredient, which is a skin pH control factor, sodium/hydrogen ion channel ( By increasing the activity of Na+/H+ Exchanger 1), black cumin (Nigella sativa), which is more essential and continuously maintains the skin pH in a weakly acidic state, improves the skin barrier function, and has an excellent effect on skin flexibility and moisturizing It relates to a cosmetic composition for adjusting skin pH comprising an extract as an active ingredient.
그러나, 상기 종래의 블랙커민 추출물을 유효성분으로 포함하는 화장료 조성물은 블랙커민을 원료로 얻기 힘들어, 우리 주위에서 재배하기 쉬운 원물을 이용한 피부 pH 조절용 화장품을 필요로 하게 되었다. 또한, 상기 종래의 블랙커민 추출물을 유효성분으로 포함하는 화장료 조성물은 pH 조절 효과가 미미하였다.However, the conventional cosmetic composition containing black cumin extract as an active ingredient is difficult to obtain black cumin as a raw material, so there is a need for cosmetics for adjusting skin pH using raw materials that are easy to grow around us. In addition, the cosmetic composition comprising the conventional black cumin extract as an active ingredient had a slight pH control effect.
따라서, 우리 주위에서 쉽게 구할 수 있되, 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써 약산성 피부 유지 및 피부 장벽 강화 효과를 가지며, 그 외에 피부에 이로운 효과를 갖는 신규한 화장료 조성물의 필요성이 커지고 있었다.Therefore, it is easily available around us, but by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, it maintains weakly acidic skin and strengthens the skin barrier. The need for cosmetic compositions was growing.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
(특허문헌 0001) 대한민국 등록특허공보 제10-2014395호(2019.08.26. 공고), "블랙커민(Nigella sativa)추출물을 유효성분으로 포함하는 화장료 조성물"(Patent Document 0001) Republic of Korea Patent Publication No. 10-2014395 (published on Aug. 26, 2019), "Cosmeceutical composition containing black cumin extract as an active ingredient"
본 발명은 화장료 조성물에 관한 것으로, 더 자세하게는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여, 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써, 약산성 피부 유지 및 피부 장벽 강화 효과를 가지며, 그 외에 피부에 이로운 다양한 효과를 갖도록 한 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition, and more particularly, by containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, maintaining weakly acidic skin and It relates to a cosmetic composition containing, as an active ingredient, a mixture of rosmarinic acid and lemon balm leaf extract, which has a skin barrier strengthening effect and has various other beneficial effects on the skin.
상기와 같은 목적을 달성하기 위하여, 본 발명은 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시키는 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물을 제공한다.In order to achieve the above object, the present invention contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient to increase the expression of NHE1 (sodium hydrogen exchanger1), an internal factor that controls skin pH, rosmarinic acid and It provides a cosmetic composition containing a mixture of lemon balm leaf extract as an active ingredient.
또한, 상기 로즈마린산과 레몬밤잎추출물의 혼합물은, 파우더 상의 로즈마린산과 레몬밤잎추출물을 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 용매에 용해하고 교반하여 혼합한 것을 특징으로 한다.In addition, the mixture of rosmarinic acid and lemon balm leaf extract is dissolved in powdered rosmarinic acid and lemon balm leaf extract in one or more solvents selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol and stirred and mixed.
또한, 상기 로즈마린산과 레몬밤잎추출물은 0.01 ~ 10 : 0.1 ~ 90의 중량비로 혼합되는 것을 특징으로 한다.In addition, the rosmarinic acid and lemon balm leaf extract are mixed in a weight ratio of 0.01 to 10: 0.1 to 90.
또한, 상기 레몬밤잎추출물은 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 추출용매로 열수추출된 것을 특징으로 한다.In addition, the lemon balm leaf extract is characterized by hot water extraction with at least one extraction solvent selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol.
또한, 로즈마린산과 레몬밤잎추출물의 혼합물을 전체 중량 대비 0.001 ~ 90.0 중량% 포함하는 것을 특징으로 한다.In addition, it is characterized in that it contains a mixture of rosmarinic acid and lemon balm leaf extract in an amount of 0.001 to 90.0% by weight based on the total weight.
본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여, 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써 약산성 피부 유지 및 피부 장벽 강화 효과를 가지며, 그 외에 안티폴루션효과, 블랙헤드제거효과 및 주름개선효과 등 피부에 이로운 다양한 효과를 갖는다.The cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, and the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that controls skin pH It has the effect of maintaining weakly acidic skin and strengthening the skin barrier by increasing
도 1은 실시예 1 내지 3 및 비교예 1 내지 2의 NHE1 mRNA 발현 증가율을 나타낸 그래프.1 is a graph showing the increase rate of NHE1 mRNA expression in Examples 1 to 3 and Comparative Examples 1 to 2;
도 2는 실시예 1 내지 3 및 비교예 1 내지 2의 NHE1 단백질 생성 촉진율을 나타낸 그래프.2 is a graph showing the NHE1 protein production promotion rate of Examples 1 to 3 and Comparative Examples 1 to 2;
도 3은 제조예 2 및 비교제조예 1 내지 3을 도포하고 시간경과에 따른 피부 pH 변화를 나타낸 그래프.3 is a graph showing changes in skin pH over time after applying Preparation Example 2 and Comparative Preparation Examples 1 to 3;
도 4는 제조예 2 및 비교제조예 1 내지 3를 도포하고 시간경과에 따른 경피수분손실량 변화를 나타낸 그래프.4 is a graph showing the change in the amount of transdermal moisture loss over time after applying Preparation Example 2 and Comparative Preparation Examples 1 to 3;
도 5는 실시예 1 내지 3 및 비교예 1 내지 2의 오염물질에 대한 세포증식율을 나타낸 그래프.5 is a graph showing the cell proliferation rate for the contaminants of Examples 1 to 3 and Comparative Examples 1 and 2;
도 6은 제조예 2 및 비교제조예 1 내지 3의 블랙헤드 제거 효과를 나타낸 그래프.6 is a graph showing the blackhead removal effect of Preparation Example 2 and Comparative Preparation Examples 1 to 3;
도 7은 실시예 1 내지 3 및 비교예 1 내지 2의 콜라겐 합성율을 나타낸 그래프.7 is a graph showing the collagen synthesis rate of Examples 1 to 3 and Comparative Examples 1 and 2;
이하의 본 발명에 관한 상세한 설명들은 본 발명이 실시될 수 있는 실시 예이고 해당 실시 예의 예시로써 도시된 첨부 도면을 참조한다. 이들 실시 예는 당 업자가 본 발명의 실시에 충분하도록 상세히 설명된다. 본 발명의 다양한 실시 예는 서로 다르지만 상호 배타적일 필요는 없음이 이해되어야 한다. 예를 들어, 여기에 기재되어 있는 특정 형상, 구조 및 특성은 일 실시 예에 관련하여 본 발명의 사상 및 범위를 벗어나지 않으면서 다른 실시 예로 구현될 수 있다. 또한, 각각의 기재된 실시예 내의 개별 구성요소의 위치 또는 배치는 본 발명의 사상 및 범위를 벗어나지 않으면서 변경될 수 있음이 이해되어야 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The following detailed description of the present invention is an embodiment in which the present invention may be practiced, and reference is made to the accompanying drawings shown by way of example of the embodiment. These embodiments are described in sufficient detail to enable those skilled in the art to practice the present invention. It should be understood that various embodiments of the present invention are different but need not be mutually exclusive. For example, specific shapes, structures, and characteristics described herein may be implemented in other embodiments without departing from the spirit and scope of the invention in relation to one embodiment. In addition, it should be understood that the location or arrangement of individual components within each described embodiment may be changed without departing from the spirit and scope of the present invention.
따라서 후술되는 상세한 설명은 한정적인 의미로서 취하려는 것이 아니며, 본 발명의 범위는 적절하게 설명된다면 그 청구항들이 주장하는 것과 균등한 모든 범위와 더불어 첨부된 청구항에 의해서만 한정된다. 도면에서 유사한 참조부호는 여러 측면에 걸쳐서 동일하거나 유사한 기능을 지칭한다.Accordingly, the detailed description set forth below is not intended to be taken in a limiting sense, and the scope of the present invention, if properly described, is limited only by the appended claims, along with all scopes equivalent to those claimed by the claims. Like reference numerals in the drawings refer to the same or similar functions throughout the various aspects.
본 발명에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in the present invention have been selected as currently widely used general terms as possible while considering the functions in the present invention, but these may vary depending on the intention or precedent of a person skilled in the art, the emergence of new technology, and the like. In addition, in a specific case, there is a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the corresponding invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than the name of a simple term.
본 발명에서 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In the present invention, when a part "includes" a certain component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.
이하, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물에 대하여 자세히 설명한다.Hereinafter, a cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient will be described in detail.
본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은, 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시키며, 안티폴루션효과, 블랙헤드제거효과 및 주름개선효과 등 피부에 이로운 다양한 효과를 갖는다.The cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient according to the present invention contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient to control the skin pH. Expression of NHE1 (Sodium hydrogen exchanger1) It has various beneficial effects on the skin such as anti-pollution effect, blackhead removal effect and wrinkle improvement effect.
상기 로즈마린산(rosmarinic acid)은 로즈마리, 깻잎, 레몬 등의 다양한 식물에 풍부하게 존재하는 폴리페놀(polyphenol) 화합물의 일종이다. 로즈마린산은 폴리페놀 성분으로서 항산화 효과 등의 다양한 약리 효능을 가지고 있는 것으로 연구되고 있다. 상기 로즈마린산은 하기 화학식 1의 형태를 갖는다.The rosmarinic acid is a kind of polyphenol compound abundantly present in various plants such as rosemary, sesame leaf, and lemon. As a polyphenol component, rosmarinic acid has been studied to have various pharmacological effects such as antioxidant effect. The rosmarinic acid has the form of Formula 1 below.
Figure PCTKR2021017657-appb-C000001
Figure PCTKR2021017657-appb-C000001
상기 로즈마린산은 디히드록시페닐젖산[3-(3,4-dihydroxyphenyl) lactic acid]의 카페익산 에스테르(caffeic acid ester)이다. 상기 로즈마린산은 1958년 스카르파티와 오리엔테(M. L. Scarpatti and G. Oriente)에 의해 로즈마리로부터 처음 추출 및 분석되었다. 상기 로즈마린산은 파우더 형태를 갖는 것을 사용하는 것이 적절하며, 파우더 형태의 로즈마린산은 다양한 제품들이 시중에 판매 중이다.The rosmarinic acid is a caffeic acid ester of dihydroxyphenyl lactic acid [3- (3,4-dihydroxyphenyl) lactic acid]. The rosmarinic acid was first extracted and analyzed from rosemary by M. L. Scarpatti and G. Oriente in 1958. It is appropriate to use the rosmarinic acid in powder form, and various products are commercially available for the rosmarinic acid in powder form.
상기 레몬밤잎추출물은 레몬밤(Melissa officinalis)의 잎으로부터 추출한 추출물을 칭한다. 상기 레몬밤은 쌍떡잎식물 꿀풀과의 내한성 다년초다. 상기 레몬밤은 레몬향이 나기 때문에 멜리스 시트로넬(melisse citronnelle)이라고도 불린다. 상기 레몬밤의 알코올성 추출물은 심장을 강화하고 두통을 완화하는 효능으로 알려진 물약인 카멜리트 워터(l'eau des Carmes)의 원료로 쓰인다. 상기 레몬밤은 꽃, 잎, 줄기 모두를 이용할 수 있고, 에센셜 오일을 유효 물질로 이용한다. The lemon balm leaf extract refers to an extract extracted from the leaves of lemon balm ( Melissa officinalis ). The lemon balm is a cold-resistant perennial plant of the dicotyledonous plant Lamiaceae. The lemon balm is also called melisse citronnelle because it smells like lemon. The alcoholic extract of lemon balm is used as a raw material for l'eau des Carmes, a potion known to strengthen the heart and relieve headaches. The lemon balm can use all of flowers, leaves, and stems, and essential oil is used as an active substance.
한편, 상기 레몬밤잎추출물은 레몬밤의 잎을 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 추출용매에 넣고 열수 추출하여 얻어진 것이 바람직하다. 보다 구체적으로, 레몬밤의 잎을 추출용매에 넣고 70 ~ 120℃의 온도에서 30 ~ 240분간 가열하여 얻어진 것일 수 있다.On the other hand, the lemon balm leaf extract is preferably obtained by hot water extraction of lemon balm leaves into one or more extraction solvents selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol. . More specifically, it may be obtained by putting leaves of lemon balm in an extraction solvent and heating at a temperature of 70 to 120° C. for 30 to 240 minutes.
상기 로즈마린산과 레몬밤잎추출물의 혼합물은, 파우더 상의 로즈마린산과 레몬밤잎추출물을 용매에 용해하고 교반하여 혼합한 것을 지칭한다.The mixture of rosmarinic acid and lemon balm leaf extract refers to a mixture of powdered rosmarinic acid and lemon balm leaf extract dissolved in a solvent and stirred.
이때, 상기 용매는 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상인 것이 적절하다. 보다 적절하게는 정제수 또는 부틸렌글라이콜인 것이 적절하다.In this case, it is appropriate that the solvent is at least one selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol. More suitably, it is purified water or butylene glycol.
한편, 상기 로즈마린산과 레몬밤잎추출물의 혼합물은, 로즈마린산과 레몬밤잎추출물이 0.01 : 10 ~ 0.1 : 90의 중량비로 혼합하여 용매에 용해시킨 것이 바람직하다. 잔량으로는 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 용매를 포함할 수 있다.On the other hand, the mixture of rosmarinic acid and lemon balm leaf extract is preferably dissolved in a solvent by mixing rosmarinic acid and lemon balm leaf extract in a weight ratio of 0.01:10 to 0.1:90. The remaining amount may include any one or more solvents selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol.
한편, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은, 로즈마린산과 레몬밤잎추출물의 혼합물 외에, 정제수, 카프릴릭/카프릭트리글리세라이드, 세테아릴알코올, 다이메티콩, 1,2-엑산디올, 세테아릴 올리베이트, 소르비탄올리베이트, 카보머, 트로메타민, 에칠헥실글리세린 및 시트릭애씨드 등을 더 포함하여 제형화된 것일 수 있다. 상기 성분들을 포함하여 제형화할 때, 로즈마린산과 레몬밤잎추출물의 혼합물을 조성물 전체 중량 대비 0.001 ~ 90.0 중량%로 포함하고 그 외에 기타 성분들을 포함하는 것이 바람직할 것이다.On the other hand, the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient, in addition to the mixture of rosmarinic acid and lemon balm leaf extract, purified water, caprylic/capric triglyceride, cetearyl alcohol, dimethy Soybean, 1,2-exandiol, cetearyl olivate, sorbitan olivate, carbomer, tromethamine, ethylhexyl glycerin and citric acid may be formulated to further include. When formulating including the above ingredients, it will be preferable to include a mixture of rosmarinic acid and lemon balm leaf extract in an amount of 0.001 to 90.0% by weight based on the total weight of the composition, and other ingredients.
한편, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은, 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시켜 약산성 피부 유지 효과를 가지며, 피부 장벽 강화 효과를 갖는다.On the other hand, the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient increases the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, has a weakly acidic skin maintenance effect, It has a barrier strengthening effect.
또한, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은, 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여, 안티폴루션효과, 블랙헤드제거효과 및 주름개선효과 등 피부에 이로운 다양한 효과를 갖는다.In addition, the cosmetic composition comprising a mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, thereby providing anti-pollution effect, blackhead removal effect and wrinkle improvement effect It has a variety of beneficial effects on the skin.
이하, 하기의 실시예, 비교예, 제조예, 비교제조예 및 실험예를 통하여 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물이 갖는 효과에 대하여 자세히 설명한다.Hereinafter, the effect of the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient will be described in detail through the following Examples, Comparative Examples, Preparation Examples, Comparative Preparation Examples and Experimental Examples.
실시예 1 내지 3. 로즈마린산과 레몬밤잎추출물의 혼합물의 제조Examples 1 to 3. Preparation of a mixture of rosmarinic acid and lemon balm leaf extract
하기의 제조 단계를 거쳐 실시예 1 내지 3의 로즈마린산과 레몬밤잎추출물의 혼합물을 제조하였다.A mixture of rosmarinic acid and lemon balm leaf extract of Examples 1 to 3 was prepared through the following preparation steps.
(S10): 로즈마린산 파우더를 준비하였다.(S10): Rosmarinic acid powder was prepared.
(S20): 레몬밤의 잎을 정제수에 넣고 90℃의 온도에서 120분간 가열하여 레몬밤잎추출물을 제조하였다.(S20): Lemon balm leaf extract was prepared by putting leaves of lemon balm in purified water and heating at a temperature of 90° C. for 120 minutes.
(S30): 1,3-부틸렌글라이콜에, 로즈마린산 파우더, 레몬밤잎추출물을 하기 표 1의 조성비로 혼합하고 교반하여 실시예 1 내지 3의 로즈마린산과 레몬밤잎추출물의 혼합물을 제조하였다.(S30): A mixture of rosmarinic acid and lemon balm leaf extract of Examples 1 to 3 was prepared by mixing 1,3-butylene glycol, rosmarinic acid powder, and lemon balm leaf extract in the composition ratio shown in Table 1 below and stirring.
혼합 중량비 (중량%)Mixed weight ratio (wt%)
실시예1Example 1 실시예2Example 2 실시예3Example 3
1,3-부틸렌클라이콜1,3-butylene glycol 잔량remaining amount 잔량remaining amount 잔량remaining amount
레몬밤잎추출물Lemon Balm Leaf Extract 50.0 50.0 50.0 50.0 50.0 50.0
로즈마린산 파우더Rosmarinic Acid Powder 0.1 0.1 1.0 1.0 2.0 2.0
비교예 1. 로즈마린산만 포함된 혼합물의 제조Comparative Example 1. Preparation of a mixture containing only rosmarinic acid
하기의 제조 단계를 거쳐 비교예 1의 로즈마린산만 포함된 혼합물을 제조하였다.A mixture containing only rosmarinic acid of Comparative Example 1 was prepared through the following preparation steps.
(S10): 로즈마린산 파우더를 준비하였다.(S10): Rosmarinic acid powder was prepared.
(S20): 1,3-부틸렌글라이콜에, 로즈마린산 파우더를 하기 표 2의 조성비로 혼합하고 교반하여 비교예 1의 로즈마린산만 포함된 혼합물을 제조하였다.(S20): A mixture containing only rosmarinic acid of Comparative Example 1 was prepared by mixing 1,3-butylene glycol with rosmarinic acid powder at the composition ratio shown in Table 2 below and stirring.
혼합 중량비 (중량%)Mixed weight ratio (wt%)
비교예1Comparative Example 1
1,3-부틸렌클라이콜1,3-butylene glycol 잔량remaining amount
로즈마린산 파우더Rosmarinic Acid Powder 1.01.0
비교예 2. 레몬밤잎추출물만 포함된 혼합물의 제조Comparative Example 2. Preparation of a mixture containing only lemon balm leaf extract
하기의 제조 단계를 거쳐 비교예 2의 레몬밤잎추출물만 포함된 혼합물을 제조하였다.A mixture containing only the lemon balm leaf extract of Comparative Example 2 was prepared through the following preparation steps.
(S10): 레몬밤의 잎을 정제수에 넣고 90℃의 온도에서 120분간 가열하여 레몬밤잎추출물을 제조하였다.(S10): Lemon balm leaf extract was prepared by putting leaves of lemon balm in purified water and heating at a temperature of 90° C. for 120 minutes.
(S20): 1,3-부틸렌글라이콜에, 레몬밤잎추출물을 하기 표 3의 조성비로 혼합하고 교반하여 비교예 2의 레몬밤잎추출물만 포함된 혼합물을 제조하였다.(S20): A mixture containing only the lemon balm leaf extract of Comparative Example 2 was prepared by mixing the lemon balm leaf extract with 1,3-butylene glycol at the composition ratio shown in Table 3 below and stirring.
혼합 중량비 (중량%)Mixed weight ratio (wt%)
비교예2Comparative Example 2
1,3-부틸렌글라이콜1,3-butylene glycol 잔량remaining amount
레몬밤잎추출물Lemon Balm Leaf Extract 50.050.0
제조예production example 1 내지 3 및 1 to 3 and 비교제조예Comparative Preparation Example 1 내지 3. 1 to 3. 실시예Example 1 내지 3 및 1 to 3 and 비교예comparative example 1 내지 2를 이용한 화장료 제형의 제조 Preparation of cosmetic formulations using 1-2
상기 실시예 1 내지 3 및 비교예 1 내지 2에서 제조된 혼합물을 화장료 제형으로 제조하였다.The mixtures prepared in Examples 1 to 3 and Comparative Examples 1 to 2 were prepared as cosmetic formulations.
실시예 1 내지 3 및 비교예 1 내지 2에서 제조된 혼합물에 정제수, 카프릴릭/카프릭트리글리세라이드, 세테아릴알코올, 다이메티콘, 1,2-헥산디올, 세테아릴 올리베이트, 소르비탄올리베이트, 카보머, 트로메타민, 에칠헥실글리세린 및 시트릭애씨드를 더 포함하여 하기 표 4와 같이 제조예 1 내지 3 및 비교제조예 1 내지 2의 화장료로 제형화하였다. 한편, 실시예 1 내지 3 및 비교예 1 내지 2에서 제조된 혼합물이 아무것도 포함되지 않은 비교제조예 3도 함께 제조하였다.Purified water, caprylic/capric triglyceride, cetearyl alcohol, dimethicone, 1,2-hexanediol, cetearyl olivate, and sorbate in the mixtures prepared in Examples 1 to 3 and Comparative Examples 1 to 2 Bitanolivate, carbomer, tromethamine, ethylhexyl glycerin and citric acid were further included and formulated as the cosmetics of Preparation Examples 1 to 3 and Comparative Preparation Examples 1 and 2 as shown in Table 4 below. On the other hand, Comparative Preparation Example 3 in which none of the mixtures prepared in Examples 1 to 3 and Comparative Examples 1 to 2 were included were also prepared.
혼합 중량비 (중량%)Mixed weight ratio (wt%)
제조예1Preparation Example 1 제조예2Preparation Example 2 제조예3 Preparation 3 비교제조예1Comparative Preparation Example 1 비교제조예2Comparative Preparation Example 2 비교제조예3Comparative Preparation Example 3
정제수Purified water 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount
실시예1Example 1 2.02.0 -- -- -- -- --
실시예2Example 2 -- 2.02.0 -- -- -- --
실시예3Example 3 -- -- 2.02.0 -- -- --
비교예1Comparative Example 1 -- -- -- 2.02.0 -- --
비교예2Comparative Example 2 -- -- -- -- 2.02.0 --
카프릴릭/카프릴트리글리세라이드Caprylic/Caprylic Triglyceride 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0
세테아릴알코올cetearyl alcohol 2.52.5 2.52.5 2.52.5 2.52.5 2.52.5 2.52.5
다이메티콘dimethicone 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0
1,2-헥산다이올1,2-Hexanediol 1.351.35 1.351.35 1.351.35 1.351.35 1.351.35 1.351.35
세테아릴 올리베이트cetearyl olivate 1.21.2 1.21.2 1.21.2 1.21.2 1.21.2 1.21.2
소르비탄올리베이트Sorbitan Oliveate 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8
카보머Carbomer 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3
트로메타민tromethamine 0.250.25 0.250.25 0.250.25 0.250.25 0.250.25 0.250.25
에틸헥실글리세린Ethylhexylglycerin 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15
시트릭애씨드Citric Acid 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02
실험예 1. NHE1 mRNA 발현 증가율 확인Experimental Example 1. Confirmation of increase rate of NHE1 mRNA expression
실시예 1 내지 3 및 비교예 1 내지 2에서 제조된 혼합물에 대하여 NHE1 mRNA 발현 증가율을 확인하였다.For the mixtures prepared in Examples 1 to 3 and Comparative Examples 1 to 2, the increase rate of NHE1 mRNA expression was confirmed.
정상적인 인간 표피 각질 세포 (NHEKs)를 75cm2의 플라스크 Keratinocyte Growth Medium(KGM)에서 배양한다. 트립신 처리에 의해 세포를 수집하고 KGM으로 희석하여 1.5 x 105 cells / mL의 농도를 만든 다음 2mL의 세포 혼합물을 6 웰 플레이트에 접종하고 밤새 배양한다. 그 후 KGM은 Keratinocyte Basal Medium(KBM)로 교환하고 세포를 24시간 동안 배양한다. KBM에 1000배 희석하여 녹인 실시예 1 내지 3 및 비교예 1 내지 2의 시험 샘플을 웰에 첨가하고 24시간 배양 후, 총 RNAs를 표준 방법에 따라 분리한다. 실시예 1 내지 3 및 비교예 1 내지 2의 첨가없이 배양된 세포의 총 RNAs를 동일한 방식으로 분리한다. cDNA는 200ng total RNA의 역전사로 합성한 다음, Real-time PCR 분석은 Thermal Cycler Dice® Real Time SystemⅢ (Takara Bio Inc, Otsu, Japan), TaKaRa SYBR® PrimeScriptTM RT-PCR Kit (Perfect Real Time) (Takara Bio Inc, Otsu, Japan)과 NHE1 또는 GAPDH (glyceraldehyde-3-phosphate) primer set를 이용해서 수행한다. 상대 발현은 NHE1 유전자와 GAPDH 유전자의 발현 비율(NHE1/GAPDH 비율)로 주어진다. NHE1 mRNA 발현에 대한 증진 효과는 다음 공식을 사용하여 평가하였다.Normal human epidermal keratinocytes (NHEKs) are cultured in a 75 cm 2 flask of Keratinocyte Growth Medium (KGM). Collect the cells by trypsinization and dilute with KGM to a concentration of 1.5 x 10 5 cells/mL, then inoculate 2 mL of the cell mixture into a 6-well plate and incubate overnight. After that, KGM is exchanged with Keratinocyte Basal Medium (KBM) and the cells are cultured for 24 hours. Test samples of Examples 1 to 3 and Comparative Examples 1 and 2 dissolved in KBM by 1000-fold dilution are added to the wells, and after 24 hours of incubation, total RNAs are isolated according to a standard method. Total RNAs of cells cultured without the addition of Examples 1 to 3 and Comparative Examples 1 and 2 were isolated in the same manner. cDNA was synthesized by reverse transcription of 200ng total RNA, and then real-time PCR analysis was performed using Thermal Cycler Dice ® Real Time SystemⅢ (Takara Bio Inc, Otsu, Japan), TaKaRa SYBR ® PrimeScriptTM RT-PCR Kit (Perfect Real Time) (Takara Bio Inc, Otsu, Japan) and NHE1 or GAPDH (glyceraldehyde-3-phosphate) primer set. Relative expression is given as the ratio of expression of the NHE1 gene to the GAPDH gene (NHE1/GAPDH ratio). The enhancing effect on NHE1 mRNA expression was evaluated using the following formula.
NHE1 mRNA 발현 증가율(%) = A / B x 100NHE1 mRNA expression increase rate (%) = A / B x 100
A : 시험 샘플의 NHE1 / GAPDH 비율A: NHE1/GAPDH ratio of test sample
B : 대조군의 NHE1 / GAPDH 비율B: NHE1/GAPDH ratio of control group
결과는 하기 표 5에 나타낸 바와 같다.The results are shown in Table 5 below.
NHE1 mRNA 발현 증가율(%)NHE1 mRNA expression increase rate (%)
대조군 control 100%100%
실시예1Example 1 137%137%
실시예2Example 2 166%166%
실시예3Example 3 178%178%
비교예1Comparative Example 1 136%136%
비교예2Comparative Example 2 127%127%
그 결과, 로즈마린산만 포함된 비교예 1과 레몬밤잎추출물만 포함된 비교예 2에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우의 NHE1 mRNA 발현 증가율이 월등히 높음을 확인할 수 있었다.이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다.As a result, it was confirmed that the NHE1 mRNA expression increase rate when rosmarinic acid and lemon balm leaf extract were mixed was significantly higher compared to Comparative Example 1 containing only rosmarinic acid and Comparative Example 2 containing only lemon balm leaf extract. It was confirmed that the efficacy was excellent when rosmarinic acid and lemon balm leaf extract were mixed, compared to the case of using the rosmarinic acid and the case of using only the lemon balm leaf extract alone.
실험예 2. NHE1 단백질 생성 촉진율 확인Experimental Example 2. Confirmation of NHE1 protein production promotion rate
실시예 1 내지 3 및 비교예 1 내지 2에서 제조된 혼합물에 대하여 NHE1 단백질 생성 촉진율을 확인하였다.For the mixtures prepared in Examples 1 to 3 and Comparative Examples 1 to 2, the NHE1 protein production promotion rate was confirmed.
정상적인 인간 표피 각질 세포 (NHEKs)를 75cm2의 플라스크 Keratinocyte Growth Medium(KGM)에서 배양한다. 트립신 처리에 의해 세포를 수집하고 KGM으로 희석하여 1.5 x 105cells/mL의 농도를 만든 다음 2mL의 세포 혼합물을 6 웰 플레이트에 접종하고 밤새 배양한다. 그 후 KGM은 Keratinocyte Basal Medium(KBM)로 교환하고 세포를 24시간 동안 배양한다. KBM에 1000배 희석하여 녹인 실시예 1 내지 4 및 비교예 1 내지 4를 웰에 첨가하고 48시간 배양 후, 세포를 400μL의 50 mmol/LTris-HCl 완충액(pH7.5, 150 mmol/L NaCl, 1% NonidetP40, 0.5% sodium deoxycholate와 프로테아제 억제제가 함유된)에 용해하고 원심 분리하여 세포 파편을 제거한다. 단백질 용액 100μL에 포함된 NHE1의 양은 NHE1 ELISA Kit (Cloud-Clone Corp.)로 측정한다. 동시에 20μL의 단백질 용액에서 총 단백질양을 정량했으며 총 단백질 당 NHE1의 양이 계산되었다. 실시예 1 내지 4 및 비교예 1 내지 4의 첨가 없이 세포에서 추출한 총 단백질 당 NHE1의 양을 100으로 정하고 시험 샘플의 세포에서 추출한 총 단백질 당 NHE1 생산 촉진 효과는 다음 공식을 사용하여 평가하였다.Normal human epidermal keratinocytes (NHEKs) are cultured in a 75 cm 2 flask of Keratinocyte Growth Medium (KGM). Collect cells by trypsinization and dilute with KGM to a concentration of 1.5 x 10 5 cells/mL, then inoculate 2 mL of the cell mixture into 6-well plates and incubate overnight. After that, KGM is exchanged with Keratinocyte Basal Medium (KBM) and the cells are cultured for 24 hours. Examples 1 to 4 and Comparative Examples 1 to 4 dissolved in KBM by 1000-fold dilution were added to the wells, and after 48 hours of incubation, the cells were incubated with 400 μL of 50 mmol/LTris-HCl buffer (pH7.5, 150 mmol/L NaCl, Dissolve in 1% NonidetP40, 0.5% sodium deoxycholate and protease inhibitor) and centrifuge to remove cell debris. The amount of NHE1 contained in 100 μL of the protein solution was measured with the NHE1 ELISA Kit (Cloud-Clone Corp.). Simultaneously, the amount of total protein was quantified in 20 μL of protein solution and the amount of NHE1 per total protein was calculated. The amount of NHE1 per total protein extracted from cells without the addition of Examples 1 to 4 and Comparative Examples 1 to 4 was set to 100, and the NHE1 production promoting effect per total protein extracted from cells of the test sample was evaluated using the following formula.
NHE1 단백질 생성 촉진율(%) = A / B x 100NHE1 protein production promotion rate (%) = A / B x 100
A : 시험 샘플을 가지고 있는 세포에서 추출한 총 단백질 당 NHE1의 양A: Amount of NHE1 per total protein extracted from cells containing the test sample
B : 시험 샘플 없이 세포에서 추출한 총 단백질 당 NHE1의 양B: Amount of NHE1 per total protein extracted from cells without test sample
결과는 하기 표 6에 나타낸 바와 같다.The results are shown in Table 6 below.
NHE1 단백질 생성 촉진율(%)NHE1 protein production promotion rate (%)
대조군 control 100%100%
실시예1Example 1 140%140%
실시예2Example 2 170%170%
실시예3Example 3 182%182%
비교예1Comparative Example 1 139%139%
비교예2Comparative Example 2 119%119%
그 결과, 로즈마린산만 포함된 비교예 1과 레몬밤잎추출물만 포함된 비교예 2에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우의 NHE1 단백질 생성 촉진율이 월등히 높음을 확인할 수 있었다.이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다..As a result, it was confirmed that the NHE1 protein production promotion rate was significantly higher when rosmarinic acid and lemon balm leaf extract were mixed compared to Comparative Example 1 containing only rosmarinic acid and Comparative Example 2 containing only lemon balm leaf extract. It was confirmed that the efficacy was excellent when rosmarinic acid and lemon balm leaf extract were mixed compared to the case of using alone and the case of using only lemon balm leaf extract.
실험예 3. 피부 pH 및 피부장벽 개선 효능 확인Experimental Example 3. Confirmation of skin pH and skin barrier improvement effect
제조예 2와 비교제조예 1 내지 3에서 제조한 화장료 제형에 대해 피부 pH 및 피부장벽 개선 효능을 확인하였다.For the cosmetic formulations prepared in Preparation Example 2 and Comparative Preparation Examples 1 to 3, the skin pH and skin barrier improvement efficacy was confirmed.
20명 시험대상자는 하루 2번씩, 2주간 제조예 2와 비교제조예 1 내지 3에서 제조한 화장료 제형을 양팔 전박부에 각각 도포한 후, 전박 부위에 1.2% SLS(Sodium Lauryl Sulfate) 용액을 IQ chamber 에 적하하여 시험 부위에 24시간 동안 첩포하였다. 인위적으로 피부 pH 및 TEWL 를 증가시킨 뒤 3일차, 1주차에 시험부위의 pH 및 경피수분손실량을 각각 pH meter와 Vapometer를 이용하여 측정하였다.After 20 subjects applied the cosmetic formulations prepared in Preparation Example 2 and Comparative Preparation Examples 1 to 3 to the forearms of both arms twice a day, twice a day, IQ of 1.2% Sodium Lauryl Sulfate (SLS) solution was applied to the forearms. It was dropped into the chamber and applied to the test site for 24 hours. After artificially increasing skin pH and TEWL, the pH and transdermal water loss of the test site were measured on the 3rd and 1st weeks using a pH meter and a vapometer, respectively.
결과는 하기 표 7에 피부 pH를 나타내었으며, 하기 표 8에 경피수분손실량을 나타내었다.As a result, the skin pH is shown in Table 7 below, and the amount of transdermal water loss is shown in Table 8 below.
피부 pHskin pH
손상 전before damage 손상 직후immediately after damage 3일 차Day 3 1주 차 Week 1
제조예2Preparation Example 2 4.984.98 5.475.47 5.215.21 5.065.06
비교제조예1Comparative Preparation Example 1 4.974.97 5.425.42 5.345.34 5.275.27
비교제조예2Comparative Preparation Example 2 4.964.96 5.455.45 5.325.32 5.255.25
비교제조예3Comparative Preparation Example 3 4.954.95 5.475.47 5.435.43 5.385.38
경피수분손실량transdermal water loss
손상 전before damage 손상 직후immediately after damage 3일 차Day 3 1주 차 Week 1
제조예2Preparation Example 2 7.607.60 23.5623.56 16.7816.78 8.278.27
비교제조예1Comparative Preparation Example 1 7.627.62 23.5423.54 18.5418.54 9.589.58
비교제조예2Comparative Preparation Example 2 7.657.65 23.5223.52 18.7818.78 9.689.68
비교제조예3Comparative Preparation Example 3 7.647.64 23.5123.51 19.6019.60 9.899.89
로즈마린산만 포함된 비교제조예 1과 레몬밤잎추출물만 포함된 비교제조예 2, 아무것도 포함되지 않은 비교제조예 3에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우에 외부자극에 의해 증가된 pH 와 경피수분손실량을 더 많이 감소시키는 것을 확인할 수 있었다.이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다.Compared to Comparative Preparation Example 1 containing only rosmarinic acid, Comparative Preparation Example 2 containing only lemon balm leaf extract, and Comparative Preparation Example 3 containing nothing, when rosmarinic acid and lemon balm leaf extract were mixed, the pH and transdermal moisture increased by external stimulation It was confirmed that the loss was further reduced. Accordingly, it was confirmed that the efficacy was excellent when rosmarinic acid and lemon balm leaf extract were mixed, compared to the case where only rosmarinic acid was used alone and when only lemon balm leaf extract was used.
실험예 4. 안티폴루션효과 확인Experimental Example 4. Confirmation of anti-pollution effect
실시예 1 내지 3과 비교예 1 내지 2에서 제조한 화장료 제형에 대해 안티폴루션효과를 확인하였다.The anti-pollution effect was confirmed for the cosmetic formulations prepared in Examples 1 to 3 and Comparative Examples 1 to 2.
일반적으로 공해 물질과 직접적으로 맞닿게 되는 피부 각질세포를 사용하여 공해물질에 의한 세포 손상 정도를 측정하고, 실시예 1 내지 3과 비교예 1 내지 2를 처리하고, 피부 세포 손상 억제 효과를 확인하였다. 실험은 공지된 방법에 따라 진행하였다.In general, the degree of cellular damage caused by pollutants was measured using skin keratinocytes that come in direct contact with pollutants, and Examples 1 to 3 and Comparative Examples 1 to 2 were treated, and the effect of inhibiting skin cell damage was confirmed. . The experiment was carried out according to a known method.
사람 각질 세포 HaCaT를 1×104 cells/ml 농도로 96-well plate에 200 ㎕씩 분주하여 37℃, CO2 인큐베이터에서 24시간 배양하였다. 이때, 배지는 소혈청 10%와 항생제 1%가 포함된 IMDM 배지를 이용하였다. 배양 후 소혈청과 항생제가 배제된 IMDM 배지로 교체한 다음, 벤조피렌(2.5㎍/mL), 질산암모늄(500ppm), 포름알데히드(1.5㎍/mL)를 처리한 후 실시예 1 내지 3과 비교예 1 내지 2를 1000배 희석처리하여 21시간 추가 배양하였다. 그 후 5mg/ml 농도의 MTT solution을 넣고 3시간 배양한 다음, 배지를 제거하고 dimethyl sulfoxide를 150ul 씩 각 well에 넣어주고 10분간 shaking 하고, 570nm로 흡광도를 측정하였다. 오염물을 처리하지 않은 실험군의 세포생존율을 대조군으로 하고, 대조군의 세포증식율을 100%로 하여 실시예 1 내지 3과 비교예 1 내지 2의 세포증식율을 비교하였다. 비교군은 실험군 대신 정제수만을 투입하였다.200 μl of human keratinocyte HaCaT at a concentration of 1×10 4 cells/ml was dispensed into a 96-well plate and cultured at 37° C., CO 2 in an incubator for 24 hours. In this case, IMDM medium containing 10% bovine serum and 1% antibiotic was used as the medium. After culturing, the medium was replaced with an IMDM medium excluding bovine serum and antibiotics, and then treated with benzopyrene (2.5 μg/mL), ammonium nitrate (500 ppm), and formaldehyde (1.5 μg/mL) in Examples 1 to 3 and Comparative Examples 1 to 2 were diluted 1000 times and further cultured for 21 hours. Thereafter, MTT solution of 5 mg/ml concentration was added and cultured for 3 hours. Then, the medium was removed and 150 μl of dimethyl sulfoxide was added to each well, followed by shaking for 10 minutes, and absorbance was measured at 570 nm. Cell viability of the experimental group not treated with contaminants was used as a control group, and the cell proliferation rate of the control group was 100%, and the cell proliferation rates of Examples 1 to 3 and Comparative Examples 1 and 2 were compared. In the comparison group, only purified water was added instead of the experimental group.
벤조피렌(2.5 ㎍/mL)에 대한 세포증식율(%)Cell proliferation rate (%) for benzopyrene (2.5 μg/mL) 질산암모늄(500 ppm)에 대한 세포증식율(%)Cell proliferation rate (%) for ammonium nitrate (500 ppm) 포름알데히드(1.5 ㎍/mL)에 대한 세포증식율(%)Cell proliferation rate (%) for formaldehyde (1.5 μg/mL)
대조군(오염물질 미처리군)Control group (untreated contaminant group) 100100 100100 100100
비교군(실험군 미처리군)Comparative group (experimental group, untreated group) 4242 4343 4141
실시예1Example 1 6969 7272 7676
실시예2Example 2 8787 8989 8282
실시예3Example 3 8585 8686 7979
비교예1Comparative Example 1 6666 6767 6565
비교예2Comparative Example 2 6868 6666 6868
그 결과, 로즈마린산만 포함된 비교예 1과 레몬밤잎추출물만 포함된 비교예 2에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우에 오염물질에 대항한 세포증식율이 더 우수한 것을 확인할 수 있었다.이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우의 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다.As a result, it was confirmed that the cell proliferation rate against contaminants was better when rosmarinic acid and lemon balm leaf extract were mixed compared to Comparative Example 1 containing only rosmarinic acid and Comparative Example 2 containing only lemon balm leaf extract. Accordingly, Compared to the case where only rosmarinic acid was used and the case where only the lemon balm leaf extract was used alone, it was confirmed that the efficacy was excellent when the rosmarinic acid and the lemon balm leaf extract were mixed when the rosmarinic acid and the lemon balm leaf extract were mixed.
실험예 5. 블랙헤드제거효과 확인Experimental Example 5. Confirmation of blackhead removal effect
제조예 2와 비교제조예 1 내지 3의 화장료 제형에 대해 블랙헤드제거효과를 확인하였다.The blackhead removal effect was confirmed for the cosmetic formulations of Preparation Example 2 and Comparative Preparation Examples 1 to 3.
시험은 공지된 방법에 따라 진행되었다. 블랙헤드 문제로 고민을 겪고있는 피험자 20명을 대상으로 제조예 2와 비교제조예 1 내지 3에서 제조한 화장료 제형을 사용한 경우의 블랙헤드 제거 효과를 평가하였다. 피험자 20명을 각각의 군으로 나누어 제조예 2와 비교제조예 1 내지 3의 화장료 제형을 2주간 도포하도록 하였다.The test was conducted according to a known method. The blackhead removal effect was evaluated when the cosmetic formulations prepared in Preparation Example 2 and Comparative Preparation Examples 1 to 3 were used for 20 subjects suffering from blackhead problems. 20 subjects were divided into each group and the cosmetic formulations of Preparation Example 2 and Comparative Preparation Examples 1 to 3 were applied for 2 weeks.
4주 경과 후 메이크업 전문가를 통해 실험 전 피험자들의 피부 상태 이미지와 4주 후 피험자들의 피부 상태 이미지를 비교하고 5점 척도법을 이용하여 블랙헤드 제거 정도를 평가하도록 하였고, 그 결과를 평균값으로 계산하여 표 10에 나타내었다.After 4 weeks, a makeup expert compared the skin condition images of the subjects before the experiment with the skin condition images of the subjects 4 weeks after the experiment, and evaluated the degree of blackhead removal using a five-point scale method. 10 is shown.
블랙헤드 제거 정도 (평균)Degree of blackhead removal (average)
제조예2Preparation Example 2 4.84.8
비교제조예1Comparative Preparation Example 1 3.63.6
비교제조예2Comparative Preparation Example 2 3.23.2
비교제조예3Comparative Preparation Example 3 2.42.4
그 결과, 로즈마린산만 포함된 비교제조예 1과 레몬밤잎추출물만 포함된 비교제조예 2, 아무것도 포함되지 않은 비교제조예 3에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우에 블랙헤드 제거 효과가 더 우수한 것을 확인할 수 있었다.이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우의 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다.As a result, compared to Comparative Preparation Example 1 containing only rosmarinic acid, Comparative Preparation Example 2 containing only lemon balm leaf extract, and Comparative Preparation Example 3 containing nothing, when rosmarinic acid and lemon balm leaf extract were mixed, the blackhead removal effect was better Accordingly, it was confirmed that when rosmarinic acid and lemon balm leaf extract were mixed, the efficacy was excellent when rosmarinic acid and lemon balm leaf extract were mixed, compared to when only rosmarinic acid was used alone and when only lemon balm leaf extract was used alone did
실험예 6. 콜라겐 합성율 측정Experimental Example 6. Measurement of collagen synthesis rate
실시예 1 내지 3과 비교예 1 내지 2에 대해 콜라겐합성효능을 확인하였다.For Examples 1 to 3 and Comparative Examples 1 to 2, the collagen synthesis effect was confirmed.
실험은 공지된 방법에 따라 수행되었다. 피부 섬유아세포(human dermal fibroblast)에 실시예 1 내지 3과 비교예 1 내지 2를 처리하여 콜라겐합성효능을 측정하였다. The experiment was performed according to a known method. Examples 1 to 3 and Comparative Examples 1 to 2 were treated in human dermal fibroblasts to measure the collagen synthesis effect.
피부 섬유아세포(human dermal fibroblast)를 96웰 마이크로 플레이트의 각 웰에 1×104 세포가 되도록 접종하여, DMEM에서 24시간 배양하였다. Human dermal fibroblasts were inoculated into each well of a 96-well microplate so as to become 1×10 4 cells, and cultured in DMEM for 24 hours.
섬유아세포(human dermal fibroblast, 혈청 함유 DMEM 배지가 들어 있는 96-웰 플레이트에 접종하고(3 X 103 세포/웰) 5% 농도의 CO2 배양기에서 37℃로 24시간 배양하였다. 24시간 후, 각 웰에서 배지를 제거한 후, 실시예 1 내지 3과 비교예 1내지 2를 1000배 희석하여 무혈청 배지로 처리하고, 48시간 동안 다시 배양하였다. 48시간 후, 세포 배양 배지를 수집하여 샘플을 제조하였다. 샘플 내 콜라겐량은 콜라겐 측정 키트(Takara, Japan)를 이용하여 프로콜라겐 타입 I C-펩타이드 (Procollagen Type I C-peptide : PICP)의 양을 측정하였다. 실험은 설명서에 기재된 방법에 따라 수행하였다. Human dermal fibroblasts (human dermal fibroblasts) were inoculated into a 96-well plate containing serum-containing DMEM medium (3 X 10 3 cells/well) and incubated for 24 hours at 37° C. in a 5% concentration CO 2 incubator. After removing the medium from each well, Examples 1 to 3 and Comparative Examples 1 to 2 were diluted 1000-fold, treated with a serum-free medium, and cultured again for 48 hours After 48 hours, the cell culture medium was collected and samples were collected. For the amount of collagen in the sample, the amount of Procollagen Type I C-peptide (PICP) was measured using a collagen measurement kit (Takara, Japan). The experiment was performed according to the method described in the manual. carried out.
대조군은 실시예 1 내지 3과 비교예 1 내지 2를 처리하지 않은 것이며, 비교군은 실시예 1 내지 3과 비교예 1 내지 2를 처리하지 않고, 자외선을 조사한 것을 지칭한다. 결과는 하기 표 11에 나타낸 바와 같으며, 대조군을 100%로 기준하여, 나머지 실험군을 이와 비교하였다. The control group is that Examples 1 to 3 and Comparative Examples 1 and 2 are not treated, and the comparative group is Examples 1 to 3 and Comparative Examples 1 and 2 are not treated, and ultraviolet rays are irradiated. The results are as shown in Table 11 below, and the control group was 100%, and the remaining experimental groups were compared thereto.
콜라겐 합성율(%)Collagen synthesis rate (%)
대조군 control 100100
비교군control group 7676
실시예1Example 1 135135
실시예2Example 2 175175
실시예3Example 3 184184
비교예1Comparative Example 1 130130
비교예2Comparative Example 2 129129
그 결과, 로즈마린산만 포함된 비교예 1과 레몬밤잎추출물만 포함된 비교예 2에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우에 콜라겐 합성율이 더 우수한 것을 확인할 수 있었다.콜라겐 합성율을 통해, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 개선된 주름 개선효과를 가짐을 유추할 수 있었다.As a result, it was confirmed that the collagen synthesis rate was better when rosmarinic acid and lemon balm leaf extract were mixed compared to Comparative Example 1 containing only rosmarinic acid and Comparative Example 2 containing only lemon balm leaf extract. Through the collagen synthesis rate, the present invention It could be inferred that the cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient had an improved anti-wrinkle effect.
이에 따라, 로즈마린산만 단독으로 사용한 경우와 레몬밤잎추출물만 단독으로 사용된 경우에 비해 로즈마린산과 레몬밤잎추출물이 혼합된 경우의 로즈마린산과 레몬밤잎추출이 혼합된 경우 효능이 우수함을 확인하였다.Accordingly, it was confirmed that the efficacy was excellent when rosmarinic acid and lemon balm leaf extract were mixed when rosmarinic acid and lemon balm leaf extract were mixed, compared to when only rosmarinic acid was used alone and when only lemon balm leaf extract was used alone.
결론.conclusion.
상기 실시예, 비교예, 제조예, 비교제조예 및 실험예를 통해 확인한 바와 같이, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 NHE1 mRNA 발현을 증가시키고 NHE1 단백질 생성을 촉진시키는 것을 확인할 수 있었다.As confirmed through the Examples, Comparative Examples, Preparation Examples, Comparative Preparation Examples and Experimental Examples, the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient increases NHE1 mRNA expression and increases NHE1 protein It was confirmed that it promotes the production.
이에 따라, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써, 약산성 피부 유지 효과, 경피수분손실 방지 효과 및, 피부 장벽 강화 효과 등을 가질 수 있다.Accordingly, the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient increases the expression of NHE1 (Sodium hydrogen exchanger1), thereby maintaining a weakly acidic skin effect, preventing transdermal moisture loss, and strengthening the skin barrier effect and the like.
그 외에도, 본 발명에 따른 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 안티폴루션효과, 블랙헤드제거효과 및 주름개선 효과를 추가적으로 갖고 있음을 확인할 수 있었다.In addition, it was confirmed that the cosmetic composition containing the mixture of rosmarinic acid and lemon balm leaf extract according to the present invention as an active ingredient additionally has anti-pollution effect, blackhead removal effect and wrinkle improvement effect.
다만, 상기와 같은 효과를 만족할만한 수치로 발현하기 위해서는 로즈마린산과 레몬밤잎추출물이 0.01 : 90 ~ 0.1 : 90의 중량비로 혼합되어야 함을 확인할 수 있었다.However, it was confirmed that rosmarinic acid and lemon balm leaf extract should be mixed in a weight ratio of 0.01: 90 to 0.1: 90 in order to express the above effects at a satisfactory level.
이에, 본 발명은 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현을 증가시킴으로써 약산성 피부 유지 및 피부 장벽 강화 효과를 가지며, 그 외에 안티폴루션효과, 블랙헤드제거효과 및 주름개선효과를 갖는 신규한 조성물로써 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물을 개발하였음을 명시한다.Therefore, the present invention has the effect of maintaining weakly acidic skin and strengthening the skin barrier by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that regulates skin pH, in addition to the anti-pollution effect, the blackhead removal effect and the wrinkle improvement effect It specifies that a cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient has been developed as a novel composition with
본 발명을 첨부된 도면과 함께 설명하였으나, 이는 본 발명의 요지를 포함하는 다양한 실시 형태 중의 하나의 실시 예에 불과하며, 당 업계에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 하는 데에 그 목적이 있는 것으로, 본 발명은 상기 설명된 실시예에만 국한되는 것이 아님은 명확하다. 따라서, 본 발명의 보호범위는 하기의 청구범위에 의해 해석되어야 하며, 본 발명의 요지를 벗어나지 않는 범위 내에서 변경, 치환, 대체 등에 의해 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리에 포함될 것이다. 또한, 도면의 일부 구성은 구성을 보다 명확하게 설명하기 위한 것으로 실제보다 과장되거나 축소되어 제공되는 것임을 명확히 한다.Although the present invention has been described in conjunction with the accompanying drawings, this is only one embodiment of various embodiments including the gist of the present invention, and is intended to be easily implemented by those of ordinary skill in the art. For the purpose, it is clear that the present invention is not limited to the embodiments described above. Accordingly, the protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent to that by changes, substitutions, substitutions, etc. within the scope not departing from the gist of the present invention are in the right of the present invention. will be included In addition, it is clarified that some components of the drawings are provided in an exaggerated or reduced form than in reality for more clearly explaining the configuration.

Claims (5)

  1. 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하여 피부 pH를 조절하는 내부인자인 NHE1(Sodium hydrogen exchanger1)의 발현 증가를 통해 피부pH를 조절하는 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물. A mixture of rosmarinic acid and lemon balm leaf extract, which contains a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, is effective in controlling skin pH by increasing the expression of NHE1 (Sodium hydrogen exchanger1), an internal factor that controls skin pH. A cosmetic composition containing as an ingredient.
  2. 제1항에 있어서, According to claim 1,
    상기 로즈마린산과 레몬밤잎추출물의 혼합물은, 파우더 상의 로즈마린산과 레몬밤잎추출물을 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 용매에 용해하고 교반하여 혼합한 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물. The mixture of rosmarinic acid and lemon balm leaf extract is dissolved in any one or more solvents selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol, and stirred A cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, characterized in that the mixture is mixed.
  3. 제1항에 있어서, The method of claim 1,
    상기 로즈마린산과 레몬밤잎추출물은 0.01 ~ 10 : 0.01 ~ 90의 중량비로 혼합되는 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물. The cosmetic composition comprising a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, characterized in that the rosmarinic acid and lemon balm leaf extract are mixed in a weight ratio of 0.01 to 10: 0.01 to 90.
  4. 제1항에 있어서, The method of claim 1,
    상기 레몬밤잎추출물은 정제수, 에탄올, 메탄올, 부탄올, 프로판올, 아세톤, 부틸렌글라이콜 및 헥산디올로 이루어진 군에서 선택된 어느 하나 이상의 추출용매로 열수추출된 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물. The lemon balm leaf extract is a mixture of rosmarinic acid and lemon balm leaf extract, characterized in that it is hot-water extracted with at least one extraction solvent selected from the group consisting of purified water, ethanol, methanol, butanol, propanol, acetone, butylene glycol and hexanediol A cosmetic composition containing as an active ingredient.
  5. 제1항에 있어서, The method of claim 1,
    로즈마린산과 레몬밤잎추출물의 혼합물을 전체 중량 대비 0.001 ~ 90.0 중량% 포함하는 것을 특징으로 하는 로즈마린산과 레몬밤잎추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물. A cosmetic composition comprising a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient, characterized in that it contains 0.001 to 90.0% by weight of a mixture of rosmarinic acid and lemon balm leaf extract based on the total weight.
PCT/KR2021/017657 2020-12-14 2021-11-26 Cosmetic composition containing mixture of rosmarinic acid and lemon balm leaf extract as active ingredient WO2022131613A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2020-0174221 2020-12-14
KR1020200174221A KR102472033B1 (en) 2020-12-14 2020-12-14 Cosmetic composition containing a mixture of rosmarinic acid and lemon balm leaf extract as an active ingredient

Publications (1)

Publication Number Publication Date
WO2022131613A1 true WO2022131613A1 (en) 2022-06-23

Family

ID=82059674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/017657 WO2022131613A1 (en) 2020-12-14 2021-11-26 Cosmetic composition containing mixture of rosmarinic acid and lemon balm leaf extract as active ingredient

Country Status (2)

Country Link
KR (1) KR102472033B1 (en)
WO (1) WO2022131613A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102563292B1 (en) * 2023-04-27 2023-08-03 아이큐어 주식회사 Cosmetic composition containing extracts of Melissa officinalis, Veronica officinalis and Sarothamnus scoparius

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060147508A1 (en) * 2002-10-04 2006-07-06 Bioderm Research Concurrent Enhancement of Skin Penetration of Organic Base Active Agents and Organic Hydroxy Acid Active Agents as Their Ion-Pair Complexes
KR101422830B1 (en) * 2013-12-04 2014-07-24 주식회사 씨앤피코스메틱스 A COSMETIC COMPOSITION WITH EXCELLENT CONTROLLING AND MAINTAINING pH OF SKIN

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102014395B1 (en) 2013-06-05 2019-08-26 주식회사 엘지생활건강 Cosmetic compositions comprising Nigella sativa
KR101873028B1 (en) 2018-01-08 2018-07-02 (주)이시스코스메틱 Cosmetic composition containing complex extract of herbs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060147508A1 (en) * 2002-10-04 2006-07-06 Bioderm Research Concurrent Enhancement of Skin Penetration of Organic Base Active Agents and Organic Hydroxy Acid Active Agents as Their Ion-Pair Complexes
KR101422830B1 (en) * 2013-12-04 2014-07-24 주식회사 씨앤피코스메틱스 A COSMETIC COMPOSITION WITH EXCELLENT CONTROLLING AND MAINTAINING pH OF SKIN

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ADA STELMAKIENĖ, KRISTINA RAMANAUSKIENĖ, VITALIS BRIEDIS: "Release of rosmarinic acid from semisolid formulations and its penetration through human skin ex vivo", ACTA PHARMACEUTICA, vol. 65, no. 2, 1 June 2015 (2015-06-01), pages 199 - 205, XP055944383, DOI: 10.1515/acph-2015-0012 *
LEE HAE-JIN, LEE SEUNG-HUN: "Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis", ALLERGY, ASTHMA & IMMUNOLOGY RESEARCH : AAIR, vol. 6, no. 4, 1 January 2014 (2014-01-01), US , pages 276 - 287, XP055944386, ISSN: 2092-7355, DOI: 10.4168/aair.2014.6.4.276 *
LEE NOO RI, LEE HAE-JIN, YOON NA YOUNG, KIM DONGHYE, JUNG MINYOUNG, CHOI EUNG HO: "Application of Topical Acids Improves Atopic Dermatitis in Murine Model by Enhancement of Skin Barrier Functions Regardless of the Origin of Acids", ANNALS OF DERMATOLOGY, vol. 28, no. 6, 1 January 2016 (2016-01-01), KR , pages 690 - 696, XP055944388, ISSN: 1013-9087, DOI: 10.5021/ad.2016.28.6.690 *

Also Published As

Publication number Publication date
KR20220084597A (en) 2022-06-21
KR102472033B1 (en) 2022-11-29

Similar Documents

Publication Publication Date Title
WO2017119795A1 (en) Novel lactobacillus casei gfc1 strain, fermented ginseng extract using strain, and preparation method thereof
WO2022145663A1 (en) Cosmetic composition comprising dead lactic acid bacteria lactobacillus plantarum mass or culture of lactic acid bacteria for preventing or alleviating skin aging
WO2020040407A1 (en) Novel cutibacterium avidum strain, and composition for preventing or treating atopic dermatitis, comprising strain or cultured product thereof
EP3119800B1 (en) Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
WO2022131613A1 (en) Cosmetic composition containing mixture of rosmarinic acid and lemon balm leaf extract as active ingredient
WO2010079978A2 (en) Composition for improving inflammatory disease using abh antigens
WO2012067404A2 (en) Composition for anti-aging containing artemisia annua l. as active ingredient
WO2022050559A1 (en) Method for preparing deinoxanthin fermented extract and cosmetic composition comprising deinoxanthin fermented extract
WO2019098808A2 (en) Composition for improving skin damage caused by microdust comprising culture or extract of aureobasidium pullulans strain
WO2022181936A1 (en) Composition inhibiting muscle loss or promoting muscle formation through skin-derived exosomes
WO2011096688A2 (en) Composition for improving scalp and hair health comprising a dibenzo-p-dioxin derivative
WO2019088421A1 (en) Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria
WO2012093738A1 (en) Composition for combating oxidation and alleviating detrimental effects on skin caused by asian dust
WO2020256297A1 (en) Anti-aging composition comprising albatrellus confluens, and preparation method for same
WO2011053007A2 (en) Composition for suppressing pore shrinkage or sebum secretion which comprises potentilla chinensis extract
WO2020209690A1 (en) Pharmaceutical composition containing wild-walnut extract, fraction thereof, or physiologically active substance derived therefrom as active ingredient, and having effects of inhibiting production of advanced glycation end products and decomposing advanced glycation end products
WO2023085612A1 (en) Method for producing fermented caviar oil using skin flora, and cosmetic composition comprising same
WO2018105799A1 (en) Cosmetic composition containing eichhornia crassipes extract as active ingredient
WO2023128426A1 (en) Cosmetic composition comprising fermented pine needle extract
WO2017074009A1 (en) Antiaging cosmetic composition containing keratin peptides as active ingredient
WO2021241953A1 (en) Fermented nano-emulsifier composition and preparation method therefor
KR101501554B1 (en) cosmetic composition including 70kDa protein from silkworm larvae hemolymph
EP3549574B1 (en) Composition for promoting hair growth or hair restoration, containing novel pantetheine-based substance
WO2012020966A2 (en) Theanine derivative, preparation method thereof, and use thereof for alleviating acne
WO2017171404A1 (en) Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21906918

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 26/10/2023)

122 Ep: pct application non-entry in european phase

Ref document number: 21906918

Country of ref document: EP

Kind code of ref document: A1